Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 16 studies | 37% ± 17% | |
peripheral blood | 16 studies | 30% ± 11% | |
intestine | 10 studies | 38% ± 21% | |
kidney | 8 studies | 38% ± 16% | |
liver | 7 studies | 34% ± 22% | |
lymph node | 6 studies | 30% ± 18% | |
eye | 6 studies | 29% ± 13% | |
brain | 6 studies | 25% ± 4% | |
pancreas | 5 studies | 49% ± 17% | |
bone marrow | 5 studies | 35% ± 12% | |
uterus | 5 studies | 41% ± 18% | |
placenta | 4 studies | 46% ± 22% | |
prostate | 4 studies | 35% ± 10% | |
breast | 4 studies | 36% ± 8% | |
adrenal gland | 3 studies | 29% ± 9% | |
esophagus | 3 studies | 46% ± 30% | |
skin | 3 studies | 27% ± 4% | |
thymus | 3 studies | 61% ± 29% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1496.51 | 1445 / 1445 | 100% | 80.86 | 183 / 183 |
liver | 100% | 1061.08 | 226 / 226 | 100% | 82.52 | 406 / 406 |
ovary | 100% | 2659.02 | 180 / 180 | 100% | 118.21 | 430 / 430 |
stomach | 100% | 1447.81 | 359 / 359 | 100% | 80.12 | 286 / 286 |
uterus | 100% | 2117.45 | 170 / 170 | 100% | 116.89 | 459 / 459 |
skin | 100% | 2446.27 | 1809 / 1809 | 100% | 103.66 | 471 / 472 |
brain | 100% | 1148.78 | 2633 / 2642 | 100% | 100.23 | 705 / 705 |
lung | 100% | 1433.49 | 576 / 578 | 100% | 89.82 | 1155 / 1155 |
bladder | 100% | 1962.81 | 21 / 21 | 100% | 91.15 | 502 / 504 |
breast | 100% | 2139.85 | 459 / 459 | 99% | 130.00 | 1112 / 1118 |
intestine | 100% | 1678.67 | 966 / 966 | 99% | 81.98 | 523 / 527 |
thymus | 100% | 1558.26 | 653 / 653 | 99% | 71.82 | 600 / 605 |
pancreas | 100% | 1164.07 | 327 / 328 | 99% | 67.32 | 177 / 178 |
prostate | 100% | 1675.33 | 245 / 245 | 99% | 72.99 | 496 / 502 |
kidney | 100% | 1796.85 | 89 / 89 | 98% | 50.93 | 881 / 901 |
adrenal gland | 100% | 1975.34 | 258 / 258 | 95% | 50.28 | 218 / 230 |
adipose | 100% | 1907.31 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1577.77 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 73.02 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 171.69 | 29 / 29 |
spleen | 100% | 1757.46 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 80.74 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 108.77 | 1 / 1 |
muscle | 99% | 1165.55 | 798 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 979.39 | 833 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 61% | 1543.80 | 568 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000387 | Biological process | spliceosomal snRNP assembly |
GO_0036261 | Biological process | 7-methylguanosine cap hypermethylation |
GO_1903241 | Biological process | U2-type prespliceosome assembly |
GO_0000398 | Biological process | mRNA splicing, via spliceosome |
GO_0000245 | Biological process | spliceosomal complex assembly |
GO_0046540 | Cellular component | U4/U6 x U5 tri-snRNP complex |
GO_0005686 | Cellular component | U2 snRNP |
GO_0005685 | Cellular component | U1 snRNP |
GO_0005681 | Cellular component | spliceosomal complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0071007 | Cellular component | U2-type catalytic step 2 spliceosome |
GO_0005697 | Cellular component | telomerase holoenzyme complex |
GO_0071005 | Cellular component | U2-type precatalytic spliceosome |
GO_0005683 | Cellular component | U7 snRNP |
GO_0034709 | Cellular component | methylosome |
GO_0034719 | Cellular component | SMN-Sm protein complex |
GO_0071011 | Cellular component | precatalytic spliceosome |
GO_0005829 | Cellular component | cytosol |
GO_0005684 | Cellular component | U2-type spliceosomal complex |
GO_0005682 | Cellular component | U5 snRNP |
GO_0005687 | Cellular component | U4 snRNP |
GO_0034715 | Cellular component | pICln-Sm protein complex |
GO_0071013 | Cellular component | catalytic step 2 spliceosome |
GO_0030532 | Cellular component | small nuclear ribonucleoprotein complex |
GO_0005689 | Cellular component | U12-type spliceosomal complex |
GO_0005634 | Cellular component | nucleus |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SNRPE |
Protein name | Small nuclear ribonucleoprotein E (snRNP-E) (Sm protein E) Small nuclear ribonucleoprotein E (snRNP-E) (Sm protein E) (Sm-E) (SmE) |
Synonyms | |
Description | FUNCTION: Plays a role in pre-mRNA splicing as a core component of the spliceosomal U1, U2, U4 and U5 small nuclear ribonucleoproteins (snRNPs), the building blocks of the spliceosome . Component of both the pre-catalytic spliceosome B complex and activated spliceosome C complexes . As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs . As part of the U7 snRNP it is involved in histone 3'-end processing . . FUNCTION: Plays a role in pre-mRNA splicing as a core component of the spliceosomal U1, U2, U4 and U5 small nuclear ribonucleoproteins (snRNPs), the building blocks of the spliceosome. Component of both the pre-catalytic spliceosome B complex and activated spliceosome C complexes. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs. As part of the U7 snRNP it is involved in histone 3'-end processing. . |
Accessions | P62304 A6NHK2 ENST00000367208.1 ENST00000414487.7 |